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Cell separation depends on cell-wall hydrolases
that cleave the peptidoglycan layer connecting
daughter cells. In Mycobacterium tuberculosis, this
process is governed by the predicted endopeptidase
RipA. In the absence of this enzyme, the bacterium
is unable to divide and exhibits an abnormal pheno-
type.Wehere report the crystal structure of a relevant
portion of RipA, containing its catalytic-domain and
an extra-domain of hitherto unknown function. The
structure clearly demonstrates that RipA is produced
as a zymogen, which needs to be activated to
achieve cell-division. Bacterial cell-wall degradation
assays and proteolysis experiments strongly
suggest that activation occurs via proteolytic pro-
cessing of a fully solvent exposed loop identified in
the crystal structure. Indeed, proteolytic cleavage
at this loop produces an activated form, consisting
of the sole catalytic domain. Our work provides the
first evidence of self-inhibition in cell-disconnecting
enzymes and opens a field for the design of novel
antitubercular therapeutics.
INTRODUCTION
Bacterial cellular division ends with cell disconnection, a mecha-
nism needed to disconnect the two new daughter sacculi after
the cell division is completed, or at the very late step of cell divi-
sion.
The process of daughter cell separation requires a delicate
balance of cell wall hydrolases that cleave the septa connecting
daughter cells. Cell-separating enzymes usually contain endo-
peptidase domains, like cysteine histidine amino peptidase
(CHAP) or NLPC/P60 domains, and/or glucosaminidase
domains (Layec et al., 2008, 2009; Rossi et al., 2009).
In the case of Mycobacterium tuberculosis, the causative
agent of tuberculosis (Kaufmann, 2008; Warner and Mizrahi,
2007), both enzyme types are responsible for cell separation
(Hett et al., 2007, 2008; Hett and Rubin, 2008). In particular,1184 Structure 18, 1184–1190, September 8, 2010 ª2010 Elsevier Ltresuscitation promoting factors (RpfA-E), which are respon-
sible for revival of M. tuberculosis from dormancy (Downing
et al., 2005; Kana et al., 2008; Mukamolova et al., 1998,
2002), have been shown to be transglycosylases capable of
hydrolyzing the glycosidic bonds of peptidoglycan chains
(Ruggiero et al., 2009; Telkov et al., 2006). A key enzyme
for M. tuberculosis cell division is resuscitation promoting
factor interacting protein (RipA), which is believed to cleave
peptidoglycan peptide crosslinks (Hett et al., 2008), similar to
other cell separating endopeptidases, like CwlT from Bacillus
subtilis (Fukushima et al., 2008) and Spr from Escherichia
coli (Aramini et al., 2008). This enzyme colocalizes at bacterial
septa with RpfB (Hett et al., 2007), the sole of the five Rpfs
(A–E) encoded in M. tuberculosis genome to be not dispens-
able for bacterial revival in vivo (Tufariello et al., 2006). RipA
has a remarkable effect on bacterial phenotype because ripA
depletion strains in Mycobacterium smegmatis exhibit
a decreasing growth and an abnormal phenotype, consisting
in branching and chaining bacteria (Hett and Rubin, 2008).
This makes RipA an excellent candidate as a drug target
against tuberculosis.
The effect of cell wall hydrolases is two fold: (1) they alter
mechanical properties of cell walls; and (2) they release soluble
peptidoglycans that, as recently suggested, activate the
serine/threonine kinase PknB (Kana and Mizrahi, 2010; Shah
and Dworkin, 2010; Shah et al., 2008).
In a previous study, we have determined the crystal structure
of a major portion of RpfB and suggested that the peculiarity of
RpfB (Tufariello et al., 2006), compared to the other four
members of the Rpf family, is its ability to anchor to the cell
wall using the G5 domain (Ruggiero et al., 2009).
In this study, we investigate RipA function both biochemi-
cally and structurally, by combining atomic resolution X-ray
crystallography, circular dichroism (CD) and fluorescence
spectroscopy, and mass spectrometry. Besides an atomic
resolution picture of RipA, this study yields new insights in
the functional regulation of this enzyme. Indeed, the crystal
structure clearly reveals a zymogenic nature of RipA, a finding
that is confirmed by cell wall degradation assays. Redundancy
in regulation mechanisms is of fundamental importance for this
essential cell wall hydrolase that, if not regulated, is potentially
suicidal.d All rights reserved
Table 1. Data Collection and Refinement Statistics
Data collection
Space group P212121
Unit-cell parameters a,b,c (A˚) 36.77, 65.41, 67.79
Resolution shell (A˚) 30.0–1.0
Unique reflections (n) 85,882
Average redundancy 12.2 (3.1)
Rmerge (%) 8.0 (29.2)
Completeness (%) 96.5 (72.6)
Mean I/s (I) 19.7 (3.0)
Refinement






Average atomic displacement parameters (A˚2)
Protein main chain, side chain 9.8, 13.8
Water 28.3
Root mean square deviations
Bond lengths (A˚) 0.019
Bond angle distance (A˚) 0.030
Mean coordinate error (A˚) 0.021
Values in parentheses are for the highest resolution shell (1.04–1.00 A˚).
See also Figure S1.
Figure 1. The Crystal Structure of RipA263–472 Shows Self-
Inactivation
(A) Solvent accessible surface of RipA263–472. The figure shows the blockage of
the catalytic domain (magenta) active site cleft by the PB15164 domain
(green).
(B) Ribbon representation of RipA263–472 and, in the right box, (2Fo-Fc) electron
density map at the catalytic site locking loop of the PB15164 domain. See also
Figures S1 and S2.
Structure
Structure and Function of RipARESULTS AND DISCUSSION
The Atomic Resolution Structure of RipA263–472 Reveals
a Zymogenic Nature for RipA
In RipA sequence, four distinct regions can be identified: a signal
peptide at its N terminus, two domains of unknown function
denoted in PFAM-B as PB07342 and PB015164, which are
mainly distributed in mycobacteria, and a predicted catalytic
domain of the NlpC/P60 family at its C-terminus. Based on
sequence analysis, we have cloned and expressed three RipA
variants including: RipA deprived of its signal peptide
(RipA40–472), a shorter variant containing both the PB015164
and the catalytic domains (RipA263–472), and the sole C-terminal
catalytic domain (RipA332–472). All recombinant proteins were
found to be monomeric in solution, as evidenced by both size
exclusion chromatography and light scattering (data not shown).
Crystals suitable for X-ray studies were obtained for
RipA263–472. The structure of RipA263–472 was solved using the
multiple anomalous dispersion (MAD) method and refined at
atomic resolution (1.0 A˚). For details of data processing, refine-
ment, and structure validation see Table 1 and Figure S1 (avail-
able online).
The overall crystal structure shows that its two domains, the
catalytic NlpC/P60 domain and the PB015164 domains
identified in the PFAM database, are tightly bound (Figure 1).
Surprisingly, we found that the catalytic site cleft of the enzyme
is physically blocked by the PB015164 domain. This findingStructure 18, 1184–11strongly suggests functional inactivity of the enzyme in this
form and reveals a zymogenic nature for RipA.
The structure of RipA catalytic domain comprises a central
b sheet of six antiparallel b strands, a small two-stranded b sheet
and six helices, arranged in a abbaabbbbbb topology (Figure 2).
Its putative catalytic cysteine (Cys383) is located at the
N-terminal end of a helix (a2) and is packed against the six-
stranded b sheet core (Figure 2). At this location, Cys383 facets
another conserved residue, His432, belonging to the b strand b3
(Figure 2). This histidine is hydrogen bonded to the side chain of
Glu444, which is in turn tightly anchored to Arg453 and Arg458
(Figure 2). Notably, the crystal structure shows that RipA
contains a Cys-His-Glu catalytic triad, which is unusual in
NlpC/P60 domains (Figure 3). A similar triad (Cys-His-Asp)
characterizes another class of cysteine proteases involved in
cell separation, denoted as CHAP domain containing proteases
(Bateman and Rawlings, 2003; Rossi et al., 2009). As mentioned
above, the crystal structure shows that RipA catalytic residues
are not accessible to potential substrates (Figure 1), as they
are locked by the PB015164 domain, here denominated prodo-
main. This domain, hitherto of unknown structure and function,
contains a catalytic-cleft-blocking loop region, a b hairpin, and
a long a helix, which is nearly perpendicular to the b hairpin90, September 8, 2010 ª2010 Elsevier Ltd All rights reserved 1185
Figure 2. Topology of RipA Catalytic Domain and Zoom of the Cata-
lytic Site
Structure
Structure and Function of RipA(Figures 1 and 4). A tight interaction between the catalytic
domain and the prodomain is observed, with a total interaction
surface area of 1809 A˚2. Whereas the b hairpin is nearly
completely solvent exposed (Figure 1), both the catalytic-cleft-Figure 3. Multiple Sequence Alignment of NlpC/P60 Domains Identifie
Conserved Cys and His are highlighted in dark grey, the third catalytic residue is
1186 Structure 18, 1184–1190, September 8, 2010 ª2010 Elsevier Ltblocking loop region and the a helix, hereafter denoted as pro-
a, establish several interactions with the main core of the RipA
mature enzyme (Figure 1). Pro-a is an amphipathic helix, which
is well anchored to the mature protein by hydrophobic and
hydrogen bonding interactions. Its hydrophobic face packs
against the N-terminal part of the a1-helix and the C-terminal
part of the a3-helix (Figure 1). Furthermore, hydrogen bonds
exist between the mature enzyme and the activation loop (e.g.,
between T232 and V394).
A strongcontribution to interdomain interactions is alsogivenby
the catalytic-cleft blocking loopencompassing residues263–283,
with a total interaction surface of 899 A˚2 (50%of the interdomain
surface area). This loop displays a well-defined electron density,
consistent with its tight binding to the catalytic cleft by several
hydrogen bonds (Figure 1). These are main-chain main-chain
hydrogen bonds, between S276 and S330, I279 and H300,
main-chain side-chain hydrogen bonds between D268 and
Q331, P272 andQ331, S276 andS430, and side-chain side-chain
hydrogen bonds between D268 and R458, S276 and S402.
Besides providing the first structural description of the prodo-
main, our results elucidate its functional role. Using CD spectros-
copy, we observed that the recombinant RipA332–472, lacking the
prodomain, is still able to fold (Figure S2). This finding suggestsd by CONSURF
shown in light grey.
d All rights reserved
Figure 4. Location of Proteolytic Cleavage Sites
(A) Amino acid sequence and secondary structure elements of RipA263–472.
(B) Ribbon structure of RipA263–472 with proteolytic cleavage sites highlighted.
Structure
Structure and Function of RipAthat the prodomain is not needed for enzyme folding, as
observed for proteases of the cathepsin family (Menard et al.,
1998). Instead, the X-ray structure reported here highlights
a role of the prodomain as a regulator of the enzyme catalytic
activity. With this concept in mind, we explored the possible
mechanism that activates the zymogenic form of RipA and
unlocks the catalytic site. A suggestion comes from the X-ray
structure, which displays a peculiarly long and fully solvent
exposed loop connecting the catalytic- and the prodomains
(Figure 4). Furthermore, we observed that on storage, all
recombinant RipA forms we produced were degraded to smaller
fragments, with molecular weights (MW) close to 15 kDa. This
MW, also checked by mass spectrometry, corresponded to
the catalytic domain (residues 332–472, see Figures S3 and S4).
Limited Proteolysis Experiments
To investigate RipA vulnerability to proteases, we carried out
limited proteolysis experiments by trypsin, thermolysin, and pro-
nase (Figure 5). Using protease/enzyme concentration ratios of
1:500, these proteases were able to degrade RipA263–472 to frag-
ments of about 15 kDa (Figure 5). Cleavage sites by these prote-Structure 18, 1184–11ases were identified using LC-MS analysis. As shown in Figure 4,
all cleavage sites are located in the large and fully solvent
exposed loop, which connects the catalytic NlpC/P60 domain
and the prodomain. This shows that the connecting loop is
a vulnerability point for the enzyme, as it is highly sensitive to
proteolytic degradation. In addition, LC-MS analysis shows
that, after proteolysis at the connecting loop (Figure 4), the pro-
domain is released and further proteolyzed.
Release of the Prodomain Activates RipA
Cell wall degrading experiments were carried out using lyophi-
lized cells of Micrococcus lysodeikticus (ATCC No. 4698)
labeled with fluorescein isothiocyanate (FITC) (see Experi-
mental Procedures). Both recombinant RipA263–472 and
RipA332–472 were incubated with the FITC-labeled cells. Pepti-
doglycan hydrolyzing activity of RipA forms was evaluated by
fluorescence spectroscopy as the amount of FITC-labeled
cell wall released in solution (Figure 6). Fluorescence measure-
ments of supernatants at time intervals allowed us to charac-
terize the time course of cell degrading reaction (Figure 6).
The most evident result is that RipA332–472 is able to degrade
FITC-labeled cell wall because early incubation time intervals
and its kinetics reaches a plateau after 20 hr (Figure 6).
By contrast, RipA263–472 displayed hardly any activity after
20 hr (Figure 6). The digestion mixture deriving from the reac-
tion of RipA332–472 with FITC-conjugated cell walls was also
analyzed by reverse phase liquid chromatography (RP-HPLC).
The mass-analysis of RP-HPLC profile, followed at 434 nm
(absorption maximum of FITC), evidenced the presence of
several peptide fragments (Figure S5) labeled with a FITC
moiety, with molecular weights ranging from 900 to 1300 Da.
The chromatogram shows a main peak (17 min) containing
species with molecular weight close to 1100 Da (Figure S3).
The same analysis, conducted on supernatants in the absence
of the enzyme, evidenced no detectable cell wall fragments;
this confirmed that the release of FITC labeled fragments in
solution was due to RipA enzymatic action.
To investigate the role of the putative catalytic Cys383 in catal-
ysis, we produced a mutant of RipA332–472, where C383 was
mutated to alanine. Using this mutant in the cell degrading
experiments, we observed that its hydrolytic activity was
completely suppressed (Figure 6). The same suppression of
RipA activity was observed on treatment of the enzyme with
the sulfhydryl-alkylating reagent iodoacetamide (data not
shown). These results experimentally prove that RipA is
a cysteine protease, as they demonstrate the fundamental role
of Cys383 in catalysis. Furthermore, they confirm the result we
derived from the X-ray structure that RipA exists as an inactive
zymogen, and that removal of the prodomain activates the
enzyme (Figures 1 and 4).
Because we observed some level of instability to proteolytic
degradation of RipA variants produced, in particular on storage
(Figure S3; Figure 6), we checked whether enzyme processing
is an autocatalytic event, as observed for the lysosomal cysteine
proteases cathepsins (Menard et al., 1998; Rozman et al., 1999;
Wittlin et al., 1999). To this aim, we carried out a typical assay for
the assessment of self-processing (Rozman et al., 1999), where
the inactive mutant RipA263–472 (C383A) was incubated with
the activated Rip332–472 form at room temperature. After 16 hr,90, September 8, 2010 ª2010 Elsevier Ltd All rights reserved 1187
Figure 5. Limited Proteolysis Studies
(A) Schematic representation of RipA domains, as
defined by PFAM. The region that was found to be
sensitive todegradation is indicatedbyablackbox.
(B) Mass spectra of main RP-HPLC peaks after
limited proteolysis of RipA263–472 with trypsin, the-
molysin, andpronase.Cleavagesites are indicated.
(C) Coomassie stained SDS-PAGE after limited
proteolysis of RipA263–472 with trypsin, themolysin,
and pronase. Molecular mass markers from the
top to bottom: 45, 36, 29, 24, 20, 14.2, 6.5 kDa.
See also Figures S3 and S4.
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Structure and Function of RipASDS-PAGE analysis showed that RipA332–472 is unable to
process RipA263–472 (C383A) (Figure 7). This result unambigu-
ously showed that RipA is not self-activated, but it needs an acti-
vating mechanism. Thus far, it is unclear which mechanism is
able to activate RipA. The strong susceptibility of the loop con-
necting the catalytic and prodomains to proteolytic degradation,
aswell as the tight interdomain interactions observed in the X-ray
structure (Figure 1A) strongly suggests that activation proceeds
via proteolytic cleavage. However, because RipA is able to
interact with RpfB (Hett et al., 2008), we cannot exclude
a possible alternative activation mechanism during resuscitation
from latency, which involves a conformational change of RipA onFigure 6. Cell Wall Degrading Activity of RipA263–472, RipA332–472
C383A Mutant, and RipA332–472
RipA263–472, RipA332–472 C383Amutant, and RipA332–472 shown as grey circles,
light grey triangles, and black squares, respectively. Values were measured as
the amount of FITC-labeled cell wall released in solution on incubation with the
enzymes. The residual activity measured for RipA263–472 at 30 hr was corre-
lated, by LC-MS analysis, to the formation of small amounts of proteolytically
processed enzyme.
1188 Structure 18, 1184–1190, September 8, 2010 ª2010 Elsevier Ltd All rights reservedRpfB binding and a consequent unlock of
RipA catalytic site. It should be noted,
however, that RipA has a fundamental
role in cell disconnection of actively
growing bacteria. The collective dispens-
ability of all five Rpfs in in vitro bacterial
growth (Kana et al., 2008) makes an acti-
vation mechanism via proteolytic pro-
cessing more plausible, at least during
bacterial active growth. Consistent withthis observation, activation via proteolytic maturation is the
typical activation mechanism of cysteine proteases (Schroder
and Tschopp, 2010; Sripa et al., 2010).
In conclusion, our results provide a step forward in the molec-
ular knowledge of the structural and functional properties of RipA
in the peptidoglycan degradation process. We demonstrate that
this enzyme, vital toM. tuberculosis, exists in a zymogenic form
that needs to be activated. This evidences a regulation mecha-
nism that is likely precious for a fundamental process like
daughter cells separation. Finally, RipA is a secreted enzyme
and easily accessible to drugs. Therefore, our study opens a field
for the design of novel classes of antitubercular therapeutics.EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification
RipA variants RipA40–472 and RipA263–472 and RipA332–472 were designed
based on the protein secondary structure predictions and protein domain
organization, by consulting the PFAM database. RipA263–472 was cloned,
expressed and purified as described (Ruggiero et al., 2010). For the prepara-
tion of RipA40–472 and RipA332–472., PCR reactions were carried out to amplify
the encoding sequences using theM. tuberculosis strain H37Rv as a template
and forward oligonucleotides starting at the aspartic residue 40 and the glycine
332, respectively. NcoI/HindIII-digested fragments were cloned into the
pETM-11 and pETM-20 vectors for RipA40–472 and RipA332–472., respectively.
RipA40–472 was expressed and purified with the same procedure described
for RipA263–472 (Ruggiero et al., 2010). Differently, RipA332–472 was expressed
as an N-terminal fusion protein in E. coli BL21Star(DE3) and purified by two
consecutive Ni2+ affinity chromatographies and a gel filtration (Superdex
75 16/60). The protein was concentrated in Vivaspin concentrators, cutoff
5 kDa, and stored in 50 mM Tris/HCl, 150 mM NaCl, 5% (v/v) glycerol, pH 8.
Mutant Preparation
The plasmid expression vectors encoding the C383Amutation were generated
by site-directed mutagenesis of wild-type plasmids pETM-30-RipA263–472 and
pETM-20-RipA332–472 using the Stratagene QuikChange kit and the mutagenic
primers 50-CCGTCGGCTTCGACGCCTCAGGCCTGGTGTTG-30 and 50-CAAC
ACCAGGCCTGAGGCGTCGAAGCCGACGG-30. DNA sequencing confirmed
Figure 7. Coomassie stained SDS-PAGE after incubation of
RipA263–472 C383A mutant with RipA332–472
Note that molar ratio is 20:1, in 20 mM Tris/HCl, pH 8. Incubation time is
reported for each lane.
Structure
Structure and Function of RipAthe mutations into the recombinant plasmid sequence. Expression and purifi-
cation of the C383 ARipA mutants were carried out in the same conditions as
for their unmutated enzymes.
Limited Proteolysis Experiments
RipA263–472 was incubated at room temperature with trypsin, thermolysin, and
pronase at various protease/enzyme ratios (1:50, 1:100, 1:200, and 1:500) in
a suitable buffer containing 50 mM Tris/HCl pH 8 and 10 mM CaCl2. Samples
were taken after 30 and 90 min and the reactions stopped by adding SDS-
PAGE sample buffer. The reaction products were analyzed by SDS-PAGE.
Samples were also analyzed by mass spectrometry, after trypsin (1:50 ratio),
thermolysin (1:100 ratio), and pronase (1:500 ratio) digestion.
Mass Spectrometry Studies
MS analysis was carried out on an LCQ DECA XP Ion Trap mass spectrometer
(ThermoElectron, Milan, Italy) equipped with an OPTON ESI source (operating
at 4.2-kV needle voltage and 320C), and with a complete Surveyor HPLC
system. Narrow bore 503 2 mm C18 BioBasic LC-MS columns from Thermo-
Electron were used for the analyses. LC binary gradient was from 5% to 70%
of B (where B was CH3CN 0.05% TFA, and A H2O 0.08% TFA) in 45 min. Initial
protein concentration was 22 mM (0.5mg/mL). Threemicroliters of this solution
were injected for all analyses. Mass spectra were recorded continuously
between the mass range 400–2000 Da in positive mode. Multicharge spectra
were deconvoluted using the BioMass program implemented in the Bioworks
3.1 package provided by the manufacturer.
CD
All CD spectra were recordedwith a Jasco J-810 spectropolarimeter equipped
with a Peltier temperature control system (Model PTC-423-S). Molar ellipticity
per mean residue, [q] in deg cm23 dmol1, was calculated from the equation:
[q] = [q]obs 3 mrw 3 (10 3 l 3 C)
1, where [q]obs is the ellipticity measured in
degrees, mrw is the mean residue molecular mass (105.3 Da), C is the protein
concentration in g 3 L1, and l is the optical path length of the cell in cm. Far-
UV measurements (183–250 nm) were carried out at 20C using a 0.1 cm
optical path length cell and a protein concentration of 0.2 mg 3 mL1.
Inactivation of Cys383 RipA with Iodoacetamide
The unique sulfhydryl group of the Cys383 residue of RipA was chemically
modified through alkylation with iodoacetamide. The reaction mixture con-
tained 100 nmol (4 mg) of protein l and 0.8 ml of 250 mM iodoacetamide
(Sigma) in 50 mM NH4HCO3 (pH 8.0). The reaction was carried out for
30 min in the dark and then quenched by adding 30 ml of 2-mercaptoethanol.
The chemicalmodificationwas checked bymass spectrometry that gave as an
increased mass, compatible with the chemical modification inserted, 58 Da.
Crystallization, Data Collection, and Processing
Crystallization trials were carried out at 293 K using the hanging-drop vapor-
diffusion method. Best crystals were obtained using 5–10 mg mL1 protein
solution and 8% (v/v) 2-propanol, 16% (w/v) PEG4000 in 60mM sodium citrate
trihydrate buffer, pH 5.6 (Ruggiero et al., 2010).Structure 18, 1184–11MAD data on a cryo-cooled Se-Met derivative crystal (100 K) of RipA263–472
were collected on beamline BM14 at the ESRF (Grenoble, France) at the three
wavelengths determined from the selenium absorption spectrum. A native
data set was also recorded at the BM14 beamline (Table 1). Cryoprotection
of the crystals was achieved by a fast soaking in a solution containing glycerol
to a final concentration of 30% (v/v). The data sets were scaled and merged
using HKL2000 program package (Otwinowski and Minor, 1997). Statistics
of data collection are reported in Table 1.Structure Determination
The crystal structure of the enzyme was solved by MAD using the anomalous
signal from the Se atoms of selenomethionine-labeled. The program SOLVE
(Terwilliger, 2004) was used to localize the selenium sites present in the asym-
metric unit and to derive the experimental phases. Phases were improved by
density modification using the programs RESOLVE (Terwilliger, 2004) and
wARP (Langer et al., 2008). Crystallographic refinement was first carried out
against 95% of the measured data using the CCP4 program suite (Potterton
et al., 2003). The remaining 5% of the observed data, which was randomly
selected, was used in Rfree calculations tomonitor the progress of refinement.
The refinement in Refmac was started using data up to 1.7 A˚ resolution and
gradually increased in subsequent rounds of refinement to the highest resolu-
tions (Murshudov et al., 1997). At this stage, water molecules were incorpo-
rated into the structure in several rounds of successive refinement. This refined
model was used to carry out CGLS refinement using SHELXL97 (Sheldrick,
2008), where X-ray intensities were used in refinement calculations.
The bond distances and angles (1,2 and 1,3 distances) were restrained using
standard Engh and Huber restraints (Engh and Huber, 1991). Each round of
refinement with SHELXL consisted of 10 cycles of restrained CGLS refinement
followed by manual model adjustments using (2Fo  Fc) and (Fo  Fc)
electron-density maps. Initial rounds of restrained CGLS refinement were
carried out by keeping all atomic displacement parameters (ADPs) isotropic.
Subsequently, the ADPs were converted to anisotropic values, leading to
improved Fourier maps. At this stage, alternative conformations visible in the
electron-density maps were modeled and refined isotropically before being
refined anisotropically. The bulk solvent was modeled based on Babinet’s
principle, as implemented in the SWAT option in the SHELXL program. An
approximate isotropic behavior was attributed to solvent atoms (ISOR
restraint). The final round of refinement was carried out with the inclusion of
riding H atoms for protein residues. The positions of H atoms assigned based
on the known geometrical criteria were not refined. A blocked matrix least-
squares minimization was carried out to estimate individual parameter
uncertainties. Their mean value, as estimated after the inversion of the least
square matrix, is reported in Table 1. The protein molecule was split into five
overlapping blocks, with five residues of overlap and approximately equal
numbers of parameters. Refinement of the positional parameters of solvent
molecules was carried out in a single block. Structures were validated using
the program PROCHECK (Laskowski et al., 1996).
Cell Wall Degradation Assays
Inactivated lyophilized cells ofM. lysodeikticus (ATCC No. 4698) were labeled
with FITC by covalently linking FITC to amine groups in the cell wall. In this
reaction, 40 mg cells were incubated at 20C with 20 mg FITC (50 mg/mL) in
100 mM NaCO3, pH 8.5, protected from light. After 16 hr incubation, the reac-
tion mixture was centrifuged; the insoluble material was washed until the
supernatant was completely colorless, to eliminate unreacted fluorochrome.
The labeled insoluble material was re-suspended and stored at 20C in
a 43 reaction buffer (50 mM Tris-HCl, 10 mM MgCl2, 2 mM MnCl2, 100 mM
NaH2PO4, 50 mM KCl, 0.01% (v/v) CHAPS). RipA263–472, RipA332–472 (C383A),
and RipA332–472 were incubated with FITC-labeled cells at 30
C in the reaction
buffer; the insoluble substrate was centrifuged (16,0003 g) and soluble FITC-
conjugates were measured in triplicate with filters for excitation at 492 nm and
emission at 518 nm. The buffer alone was used to correct for background
release of FITC.ACCESSION NUMBERS
Coordinates and structure factors have been deposited in the Protein Data
Bank with accession number 3NE0.90, September 8, 2010 ª2010 Elsevier Ltd All rights reserved 1189
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